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Schwann cell c-Jun is implicated in adaptive andmaladaptive functions in peripheral nerves. In injured nerves, this transcription factor
promotes the repair Schwann cell phenotype and regeneration and promotes Schwann-cell-mediated neurotrophic support inmodels of
peripheral neuropathies. However, c-Jun is associated with tumor formation in some systems, potentially suppresses myelin genes, and
has been implicated in demyelinating neuropathies. To clarify these issues and to determine how c-Jun levels determine its function, we
have generated c-Jun OE/ and c-Jun OE/OE mice with graded expression of c-Jun in Schwann cells and examined these lines during
development, in adulthood, and after injury using RNA sequencing analysis, quantitative electron microscopic morphometry, Western
blotting, and functional tests. Schwann cells are remarkably tolerant of elevated c-Jun because the nerves of c-Jun OE/mice, in which
c-Jun is elevated6-fold, are normal with the exception of modestly reduced myelin thickness. The stronger elevation of c-Jun in c-Jun
OE/OE mice is, however, sufficient to induce significant hypomyelination pathology, implicating c-Jun as a potential player in demyeli-
nating neuropathies. The tumor suppressor P19ARF is strongly activated in the nerves of thesemice and, even in aged c-Jun OE/OEmice,
there is no evidence of tumors. This is consistent with the fact that tumors do not form in injured nerves, although they contain
proliferating Schwann cells with strikingly elevated c-Jun. Furthermore, in crushed nerves of c-Jun OE/mice, where c-Jun levels are
overexpressed sufficiently to accelerate axonal regeneration, myelination and function are restored after injury.
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Introduction
Schwann cell c-Jun has been implicated both in adaptive and
maladaptive functions in peripheral nerves. In injured nerves,
this transcription factor is a global amplifier of the repair Schwann
cell phenotype and promotes regeneration and, in models of pe-
ripheral neuropathies, Schwann cell c-Jun supports axonal sur-
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Significance Statement
In injured and diseased nerves, the transcription factor c-Jun in Schwann cells is elevated and variously implicated in controlling bene-
ficialoradverse functions, including trophicSchwanncell support forneurons,promotionof regeneration, tumorigenesis, andsuppres-
sionofmyelination.Toanalyzethefunctionsofc-Jun,wehaveusedtransgenicmicewithgradedelevationofSchwanncellc-Jun.Weshow
thathighc-Junelevation is apotentialpathogenicmechanismbecause it inhibitsmyelination.Conversely,wedidnot finda linkbetween
c-Jun elevation and tumorigenesis. Modest c-Jun elevation, which is beneficial for regeneration, is well tolerated during Schwann cell
development and in the adult and is compatiblewith restoration ofmyelination andnerve function after injury.
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vival, trophic factor expression, and sensory–motor function
(Arthur-Farraj et al., 2012, 2017; Hantke et al., 2014; Klein et al.,
2014; Jessen andMirsky, 2016). Reduced c-Jun levels in Schwann
cells are also implicated in failure of regeneration due to aging
and long-term denervation (Painter et al., 2014; Jessen and Mir-
sky, 2016). The c-Jun pathway is therefore of interest for the
development of a pharmacology for nerve repair. Conversely,
c-Jun is associated with tumor formation in some systems and
potentially suppresses myelin genes (Eferl and Wagner, 2003;
Parkinson et al., 2008). Based on this, it has been characterized as
a negative regulator of myelination and implicated in demy-
elinating neuropathies (Jessen andMirsky, 2008). In the present
work, we have generated and analyzed mouse lines with graded
expression of c-Jun in Schwann cells to clarify these issues and to
determine how c-Jun levels determine its function.
c-Jun is present at low levels in Schwann cells of uninjured
nerves, but is rapidly elevated 80- to 100-fold after nerve cut (De
Felipe and Hunt, 1994; Shy et al., 1996; Parkinson et al., 2008; J.
Gomez-Sanchez, K.R. Jessen, and R. Mirsky, unpublished data).
c-Jun elevation is also seen in human neuropathies (Hutton et al.,
2011). Although c-Jun is implicated in the promotion of a num-
ber of tumors, in other situations, it may have a role in the pre-
vention of tumorigenesis by mechanisms that include activation
of tumor suppressors such as P14ARF/p19ARFand Dmp1 (Eferl
and Wagner, 2003; Ameyar-Zazoua et al., 2005; Shaulian, 2010).
P19ARF is elevated in Schwann cells after nerve transection and
the striking activation of Schwann cell c-Jun after injury is not
associated with tumor formation (Gomez-Sanchez et al., 2013;
Jessen et al., 2015b). Rather, the role of c-Jun is to take part in
controlling the conversion ofmyelin andRemak cells to Schwann
cell specialized to perform injury-specific tasks and to promote
repair (Jessen et al., 2015a; Jessen and Mirsky, 2016; Arthur-
Farraj et al., 2017; Gomez-Sanchez et al., 2017). This includes
preventing the death of injured neurons and promoting axon
growth by expression of trophic factors, guiding axons back to
their targets by forming regeneration tracks (Bungner bands),
and breakdown ofmyelin directly by autophagy and indirectly by
cytokine expression to recruit macrophages. Inactivation of
Schwann cell c-Jun results in defective repair Schwann cells and
impaired regeneration (Arthur-Farraj et al., 2012; Jessen and
Mirsky, 2016).
The injury-induced extinction of myelin genes is also delayed
without c-Jun, indicating that c-Jun has a dual function, promot-
ing the expression of the repair phenotype and the suppression of
the myelin phenotype. c-Jun suppression of myelin genes has
only been studied directly in culture, where c-Jun suppresses the
Krox20- or cAMP-induced activation of myelin genes, and en-
forced c-Jun inhibits myelination in cocultures (Parkinson et al.,
2004, 2008). Negative transcriptional regulation of myelination
has also been shown for Notch1 and Sox2 in vivo and suggested
for other factors including Pax-3, Id2, and Sox-2 based on cell
culture experiments (Jessen and Mirsky, 2008; Roberts et al.,
2017).
The present results show that the function of c-Jun in Schwann
cells depends on gene dosage, and that Schwann cells are surpris-
ingly tolerant of the moderately (6-fold) elevated c-Jun seen in
c-Jun OE/ mice. In these mice, overexpression of c-Jun is suf-
ficient to accelerate axonal regeneration (Wagstaff et al., 2017), so
myelination and function are restored after nerve injury. Further,
even high expression of c-Jun is not associated with tumor for-
mation in Schwann cells, although this is sufficient to cause hy-
pomyelination neuropathy.
Materials andMethods
Transgenic mice
Animal experiments conformed toUKHomeOffice guidelines under the
supervision of University College London (UCL) Biological Services. To
generate mice that overexpress c-Jun selectively in Schwann cells, female
R26c-Junstopfmice, generated in the laboratory ofKlaus Rajewsky, which
carry a lox-P flanked STOP cassette in front of a CAG promoter-driven
c-Jun cDNA in the ROSA26 locus, were crossed with male P0Cre/
mice (Feltri et al., 1999). This generated P0-Cre/;R26c-Junstopf f/
mice, which we refer to as c-Jun OE/ mice. These male mice were
back-crossed with female R26c-Junstopf f/f mice to generate P0-Cre;
R26c-Junstopf f/f mice, referred to as c-Jun OE/OE mice. P0-Cre / lit-
termates were used as controls. Mice of either sex and on the C57BL/6
background were used in the experiments.
Genotyping
DNA for genotyping was extracted from ear or tail samples using the
HotSHot method (Truett et al., 2000). Primers for genotyping the R26c-
Junstopf transgene were 5-TGGCACAGCTTAAGCAGAAA-3 and 5-
GCAATATGGTGGAAAATAAC-3 (270bp). The primers for the Rosa26
wild-type locus were 5GGAGTGTTGCAATACCTTTCTGGGAGTTC-3
and 5TGTCCCTCCAATTTTACACCTGTTCAATTC-3 (217bp band).
The primers for the P0-Cre transgene were 5-GCTGGCCCAAATGTT
GCTGG-3 and 5CCACCACCTCTCCATTGCAC-3 (480 bp band).
Nerve injury
The sciatic nerve was exposed and crushed (3 15 s at 3 rotation angles)
at the sciatic notch using angled forceps. The wound was closed using
veterinary autoclips. The nerve distal to the crushwas excised for analysis
at various time points. Contralateral uninjured sciatic nerves were used
as controls for Western blotting, immunofluorescence, or electron
microscopy.
Schwann cell culture
Schwann cell cultures were prepared from sciatic nerves of postnatal day
8 (P8)–P10mouse pups essentially as inMorgan et al. (1991) andArthur-
Farraj et al. (2011). After enzymatic dissociation and centrifugation,
the cell pellet was resuspended in defined medium (DM) (Meier et al.,
1999) containing 106 M insulin and 5% horse serum (HS) and plated in
drops on coverslips coated with poly-L-lysine and laminin. Cells were
incubated at 37°C/5% CO2 and allowed to adhere for 24 h. After 24 h,
the medium was changed to DM/0.5% HS (controls), DM with 10
ng/ml NRG1 alone, or DM with NRG1 10 ng/ml and dbcAMP 1 mM for
48 h before fixation and immunolabeling.
Antibodies
The following antibodieswere used for Immunofluorescence: c-Jun (Cell
Signaling Technology, rabbit 1:800, 9165, RRID: AB_2130165), Ki67
(Abcam, rabbit 1:100, ab15580, RRID: AB_443209), Krox20 (Covance,
rabbit 1:100, PRB-236P, RRID: AB_10064079), SOX-10 (R&D Systems,
goat 1:100, AF2864, RRID: AB_442208), donkey anti-goat IgG (HL)
Alexa Fluor 488 conjugate (Invitrogen, 1:1000, A11057, RRID:
AB_2534104), Cy3 donkey anti-rabbit IgG (HL) (Jackson Immunore-
search, 1:500, 711-165-152, RRID: AB_2307443), biotinylated anti-
rabbit IgG (GE Healthcare, 1:600, RPN1004, RRID: AB_1062582), and
Cy3 Streptavidin (Jackson ImunnoResearch, 1:500, 016-160-084).
The following antibodieswere used forWestern blot: GAPDH(Sigma-
Aldrich, rabbit 1:5000, G9545, RRID: AB_796208), calnexin (Enzo Life Sci-
ences, rabbit 1:1000, ADI-SPA-860-D, RRID: AB_2038898), c-Jun (Cell
Signaling Technology, rabbit 1:1000, 9165), Krox20 (Millipore, rabbit
1:500, ABE1374, RRID: AB_2715555), Mpz (Aves Labs, chick 1:2000,
PZO, RRID: AB_2313561), cyclin D1 (Santa Cruz Biotechnology, rabbit
1:200, sc-450, RRID: AB_627342), p19 Arf (5-c3-1) (Santa Cruz Biotech-
nology, rat 1:100, sc-32748, RRID: AB_628071), anti-mouse IgG HRP-
linked (Promega, 1:2000, W4028, RRID: AB_430834), anti-rabbit
IgG, HRP-linked (Cell Signaling Technology, 1:2000, 7074, RRID:
AB_2099233), anti-rat IgG, HRP-linked (Cell Signaling Technology,
1:2000, 7077), and anti-chicken IgY, HRP-linked (Promega, 1:2000,
G1351, RRID: AB_430845).
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Immunohistochemistry
Schwann cells were fixed in 4% paraformaldehyde/PBS for 15 min and
then immunolabeled. Transverse sciatic nerve cryosections (10 m)
were postfixed with 4% paraformaldehyde/PBS for 15 min, blocked in
0.2%TritonX-100with 10%HS in PBS and subsequently incubatedwith
primary antibodies in blocking solution overnight at 4°C, followed by 2 h
in secondary antibodies and DAPI to identify cell nuclei (Thermo Fisher
Scientific, 1:50,000). ForKi67 staining, biotin antibodies followed byCy3
streptavidin were used.
Western blotting
For blotting, homogenates were obtained from injured and uninjured
nerves and from cultured nerve segments essentially as described previ-
ously (Gomez-Sanchez et al., 2015). Experiments were repeated at least
three times with fresh samples and representative photographs are shown.
Densitometric quantificationwas by Image Lab 4.1 (Bio-Rad Laboratories).
Measurements were normalized to loading control GAPDH and/or
calnexin.
RNA sequencing analysis
Library preparation. Total RNA was isolated using the RNeasy Lipid
Tissue Mini Kit (Qiagen) with a DNase I step performed to eliminate
traces of genomicDNA.The purifiedmRNAwas fragmented and primed
with randomhexamers. Strand-specific first-strand cDNAwas generated
using reverse transcriptase in the presence of actinomycin D. The second
cDNA strand was synthesized using dUTP in place of dTTP to mark the
second strand. The resultant cDNA was then “A-tailed” at the 3 end to
prevent self-ligation and adapter dimerization. Truncated adaptors con-
taining a T overhang were ligated to the A-tailed cDNA. Successfully
ligated cDNA molecules were then enriched with limited cycle PCR
(10–14 cycles). The high-fidelity polymerase used in the PCR is unable to
extend through uracil. This means that only the first strand is amplified
for sequencing, thus making the library strand specific.
Sequencing. Libraries to bemultiplexed in the same runwere pooled in
equimolar quantities. Samples were sequenced on the NextSeq 500 in-
strument (Illumina), resulting in16 million reads per sample.
Figure 1. Graded overexpression of c-Jun Schwann cell nuclei of c-Jun OE/ and c-Jun OE/OEmice.A, Genomic structure of the c-Jun floxed allele in the Rosa26 locus. Excision of the stop codon
is effected by crossing Rosa26c-Junff/micewith P0 cre-expressingmice to generate c-JunOE/ and c-JunOE/OEmice overexpressing c-Jun specifically in Schwann cells.B, PCR analysis showing
the presence of c-Jun OE, Rosa26WT, and P0 cre bands from DNA samples extracted from tails of WT, c-Jun OE/, and c-Jun OE/OE mice. C, Representative immunofluorescence images fromWT,
OE/, and OE/OE sciatic nerve cryosections showing Sox10- and c-Jun-positive nuclei. Note the graded increase in c-Jun in c-JunOE/ and c-Jun OE/OEmice. Scale bar, 50m.D, Western blot of
sciatic nerve protein extracts fromP60WT, c-Jun OE/, and c-Jun OE/OEmice showing increasing c-Jun levels. The graph quantifies c-Jun expression inWT (n 7), c-Jun OE/ (n 6), and c-Jun
OE/OE (n 6) mice. The quantifications are normalized to the levels in uninjuredWT nerves, which are set as 1. Note that the difference in c-Jun expression between c-Jun OE/ and c-Jun OE/OE
nerves is also significant. One-way ANOVAwith Tukey’s comparison; *p 0.05, ****p 0.0001. E, Representative immunofluorescence images from purified Schwann cell cultures fromWT and
c-Jun OE/mice. The cells were exposed to neuregulin (nrg) alone or neuregulin plus cAMP analog (dbcAMP), a combination that mimics axonal myelination signals. Note that neuregulin plus
dbcAMP suppresses c-Jun in WT, but not in c-Jun OE/, cells. Sox10 was used as a Schwann cell marker to show levels of c-Jun specifically in Schwann cells.
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Data analysis. Run data were demultiplexed and converted to fastq files
using Illumina’s bcl2fastq Conversion Software version 2.18 on BaseSpace.
Fastq files were aligned to a reference genome using STAR on the BaseSpace
RNA-Seq alignment app version 1.1.0. Reads per transcript were counted
using HTSeq and differential expression was estimated using the BioCon-
ductor package DESeq2 (BaseSpace app version 1.0.0).
RNA Sequencing analysis was performed by UCL Genomics, UCL
Great Ormond Street Institute of Child Health.
Electron microscopy
Nerves were processed as described previously (Gomez-Sanchez et al.,
2015). Transverse ultrathin sections from neonatal, P7, and P21 sciatic
nerve or adult (P60) or aged (P300) sciatic nerves or from injured distal
stumps of adult sciatic nerves were taken 5 mm from the sciatic notch or
cut site and mounted on film.
Photographs were taken using a Jeol 1010 electron microscope with a
Gatan camera and software. Images were analyzed using ImageJ. Photo-
graphs at were taken at 3000 to measure the number of myelinated
axons, non-myelinated axons bigger than 1.5 m, and Schwann cell
nuclei. The nerve area was measured from photographs taken at 200
magnification.Highermagnificationswere used to show theRemakbun-
dles or any abnormal morphology found in the nerve.
The percentage of extracellularmatrix was analyzed using ImageJ soft-
ware by converting electron microscopy images at 5000 and 10,000
into 8-bit images and tracing the presence of extracellular matrix.
Behavioral tests
Experiments conformed to UK Home Office guidelines. Nine or more
mice/genotype were tested. Six-week-oldmice were tested before surgery
to ensure that there were no differences in normal responses between the
genetic backgrounds. Sciatic function index (Inserra et al., 1998), toe
spread reflex (Ma et al., 2011), and the toe pinch test, modified from
Collier et al. (1961), were performed as in Arthur-Farraj et al. (2012).
Statistical analysis
Results are expressed as mean 	 SEM. Statistical significance was esti-
mated by one-way ANOVA with Tukey’s correction, two-way ANOVA
with Bonferroni’s’s multiple comparisons, Mann–Whitney U test, or
Student‘s t test. p 0.05 was considered statistically significant. Statisti-
cal analysis was performed usingGraphPad Prism software (version 6.0).
Figure 2. Gene expression in c-Jun OE/ and c-Jun OE/OEmice. A, Heat map of the 400most regulated genes in uninjured nerves of WT and c-Jun OE/OEmice. B, Principal component analysis
map of gene regulation inWT and c-Jun OE/OE nerves. C, Expression of 13 genes of interest in the sciatic nerve of OE/ and OE/OEmice. The table shows how c-Jun elevation affects the expression
of a subset of repair cellmarkers,myelinproteins, and transcription factors in themouse lines indicated.Note that, inOE/nerves, only Shh is regulated2-fold. InOE/OEnerves, repair cellmarkers
are upregulated and myelin genes are downregulated, although two important myelin regulators, Krox20 and Sox10, are not strongly affected. WT, n 3; OE/, n 4; and OE/OE, n 4.
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Figure 3. The 15 most upregulated and downregulated genes in the sciatic nerve of OE/ and OE/OE mice. A, B, The 15 most strongly elevated genes (top) and the 15 most suppressed genes
(bottom) in response to c-Jun elevation in the mouse lines indicated. C, The 15 most strongly regulated gene in OE/OE nerves compared with expression in OE/ nerves. D, Representative
immunofluorescence images fromWT, c-JunOE/, and c-JunOE/OE sciatic nerve cryosections showingKrox20 in Sox10-positive Schwann cell nuclei. Note similar Krox20expression inWTand c-Jun
OE/nerves, butmuch reduced levels in c-JunOE/OEnerves. Scale bar, 50m.E,Westernblot of sciatic nerveprotein extracts fromP60mice showing similar levels of Krox20 inWTand c-JunOE/
nerves, but lower levels in c-Jun OE/OE nerves. The graph quantifies Krox20 expression inWT (n 5), c-Jun OE/ (n 4), and c-Jun OE/OE (n 5)mice. The quantifications are normalized to the
levels in uninjuredWT nerves, which are set as 1. One-way ANOVAwith Tukey’s comparison: *p 0.05, **p 0.01. F, Western blot of sciatic nerve protein extracts from P60mice. Note that Mpz
expression is 15% lower thanWT in c-Jun OE/ nerves, but strongly suppressed in c-Jun OE/OE nerves. The graph quantifies Mpz expression inWT (n 5), c-Jun OE/ (n 4), and c-Jun OE/OE
(n 5) mice. The quantifications are normalized to the levels in uninjured WT nerves, which are set as 1. One-way ANOVA with Tukey’s comparison: ****p 0.0001.
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Figure 4. Electronmicroscopic structure of adult nerves inWT and OE/mice. A, Electronmicrographs showing similar overall appearance of nerves from P60WT and OE/mice. Scale bar, 5
m.B, Total area of P60WT and OE/mouse nerves is not significantly different. Mann–WhitneyU test: p 0.5317 (n 5). C, The number of Schwann cell nuclei per sciatic nerve profiles is not
significantly different between P60WT and OE/ nerves. Mann–Whitney U test: p 0.0952 (n 5).D, Counts of Ki67-positive/Sox10-positive nuclei indicate that the difference in Schwann cell
proliferation betweenWT and c-Jun OE/mice is not significantly different. Mann–Whitney U test: p 0.2000 (n 3). E, The total number of axons larger than 1.5m in diameter is similar in
P60WTandOE/nerves.Mann–WhitneyU test:p0.9444 (n5).F, The percentage of axons in a 1: 1 relationship and
1.5mindiameter that aremyelinated is similar in P60WTandOE/
nerves. Mann–WhitneyU test: p
 0.9999 (n 5).G, Per nerve profile, the number ofmyelinated axons is similar in P60WT and OE/ nerves. Mann–WhitneyU test: p 0.8016 (n 5).H, Per
nerve profile, the number of axons in a 1:1 relationship and
1.5m in diameter but not myelinated is not significantly different between P60WT and OE/nerves. Mann–Whitney U test: p

0.999 (n 5). I, Myelin thickness measured by g-ratios is thinner in P60 OE/ nerves compared with WT. The whiskers extend from the 5th to the 95th percentiles. Mann–Whitney U test: p
0.0079 (n 5). J, The percentage of axons
1.5m in diameter that remain unmyelinated andwithin Remak bundles is very low and similar in P60WT and OE/ nerves. Mann–WhitneyU test:
p 0.1508 (n 5). K, Electronmicrographs showing that the overall structure of adult P300 nerves inWT and OE/mice is similar. Scale bar, 5m. L, The area of transverse profiles of P300WT
(n 4) and OE/ (n 5) nerves is not statistically different. Mann–WhitneyU test: p 0.2857.M, The number of Schwann cell nuclei per sciatic nerve profile is somewhat higher in P300 OE/
(n 5) nerves comparedwithWT (n 4).Mann–WhitneyU test: p 0.0317.N, The total number of axons larger than 1.5m in diameter is similar in P300WT (n 4) and c-Jun OE/ (n 5)
nerves. Mann–Whitney U test: p  0.1905. O, The percentage of axons in a 1:1 relationship and 
1.5 m in diameter that are myelinated is similar in (Figure legend continues.)
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Results
Adult uninjured nerves of c-Jun OE/ and c-Jun OE/OEmice
have high levels of c-Jun protein in Schwann cell nuclei
A diagrammatic representation of how the c-Jun-overexpressing
mice were bred and produced is shown in Figure 1A. The R26c-
Junstopfmouse has a c-Jun cDNA insert in the Rosa26 WT locus
with two flanking loxP sites on either side of a STOP codon. These
mice were bred with P0Cre/ mice (Feltri et al., 1999). In the
presence of Cre recombinase, the STOP codon is removed and
c-Jun is overexpressed specifically in Schwann cells (Feltri et al.,
1999). P0Cre /;R26c-Junstopf f/ control mice will be referred
to asWTmice, P0Cre/; R26c-Junstopf f/will be referred to as
c-Jun OE/ mice, and P0Cre/; R26c-Junstopf f/f will be re-
ferred to as c-Jun OE/OEmice. Genotyping of WT, c-Jun OE/,
and c-Jun OE/OE mice is shown in Figure 1B.
We examined c-Jun protein expression in adult (P60) unin-
jured sciatic nerves of c-Jun OE/ and c-Jun OE/OE mice and
compared this with that seen in WT mice. Double immunola-
beling with c-Jun antibodies and Sox10 antibodies to identify
Schwann cell nuclei specifically showed that Schwann cells in
c-JunOE/ nerves expressed clearly elevated nuclear c-Jun levels
compared with that seen in WT nerves, which showed barely
detectable c-Jun using this staining protocol (see Materials and
Methods). In c-Jun OE/OE nerves, nuclear c-Jun levels were fur-
ther increased (Fig. 1C). No increase in c-Jun was seen in Sox10-
negative nuclei labeled with DAPI (data not shown), indicating
that c-Jun overexpression in these mouse lines was Schwann cell
specific, in agreement with previous observations (Feltri et al.,
1999).
Western blotting showed that c-Jun protein levels in unin-
jured adult sciatic nerves were elevated 6-fold in c-Jun OE/
mice and 28-fold in c-Jun OE/OE mice compared with WT
(Fig. 1D). In c-Jun OE/mice, c-Jun mRNA levels were 4.5-fold
higher than in WT nerves.
These data indicate that the axonal signals that normally sup-
press c-Jun during myelination in vivo fail to supress c-Jun ex-
pression from the c-Jun OE transgene, as expected (Jessen and
Mirsky, 2008; Parkinson et al., 2008). We verified this by expos-
ing purified Schwann cell cultures to signals that mimic axonal
myelin signals inmice, namely the combined activation of cAMP
and neuregulin pathways (Arthur-Farraj et al., 2011). In these
experiments, a combination of 1 mM dbcAMP and 10 nM neu-
regulin failed to suppress nuclear c-Jun expression in c-JunOE/
cells, although downregulation of c-Jun protein was seen in WT
cells (Fig. 1E).
The elevation of c-Jun specifically in Schwann cell nuclei in
c-Jun OE/ and c-Jun OE/OE mice allowed us to study in vivo
the effects of a graded increase in c-Jun expression on Schwann
cells in uninjured and injured nerves.
Transcriptional profiling of uninjured nerves inWT, c-Jun
OE/, and c-Jun OE/OE mice
To document changes in gene expression caused by c-Jun el-
evation in c-Jun OE/ and OE/OE mice, we performed RNA
sequencing analysis on uninjured adult (P60) sciatic nerves.
Heat-map and principal component analysis confirmed that
c-Jun overexpression was the dominant source of differential
gene expression (Fig. 2A,B). In OE/ nerves, which express6-
fold WT levels of c-Jun protein, 67 genes were 2-fold upregu-
lated and 25 genes were 2-fold downregulated compared with
WT nerves. Among 13 genes that we considered of particular
interest, one gene, Shh, was upregulated2-fold (Fig. 2C). c-Jun
was expressed at 153% of WT levels and GDNF at 182% of WT
levels and the myelin protein genesMbp andMpzwere expressed
at65% and 75%ofWT levels, respectively. ThemRNA level for
Krox20 (Egr2), a keymyelin regulator, was essentially unchanged.
The 15 most upregulated and downregulated genes in c-Jun
OE/ are shown in Figure 3A.
In OE/OE nerves, which express28-fold WT levels of c-Jun
protein, 909 genes were 2-fold upregulated and 1055 genes
were2-fold downregulated comparedwithWTnerves.Most of
the 13 genes of particular interest changed expression by2-fold
in thesemice (Fig. 2C).This included c-Jun, whichwas elevated 4-
to 5-fold; Gdnf, which was elevated by 56-fold; and Shh and
Olig1, which were elevated 20-fold and 48-fold, respectively. The
myelin protein genes Mbp and Mpz were reduced to 13–14% of
WT levels. The 15 most upregulated and downregulated genes in
c-Jun OE/OE nerves are shown in Figure 3B.
A comparison of gene expression between OE/ and OE/OE
mice with respect to the 13 genes of interest and the most regu-
lated genes is shown in Figures 2C and 3C, respectively.
The fact that c-Junproteinwasmore strongly elevated in termsof
fold change from WT than c-Jun mRNA in both c-Jun OE/ and
OE/OE mice suggests that posttranscriptional controls are impor-
tant in controlling c-Jun levels. RNA-Seq data were deposited in
ArrayExpress (https://www.ebi.ac.uk/arrayexpress/) with accession
ID: E-MTAB-6138.
Expression of myelin-related proteins in uninjured nerves of
OE/ and OE/OE mice
We examined two key myelin-related proteins, the promyelin
transcription factor Krox20 (Egr2) and the myelin adhesion pro-
tein Pzero (Mpz), in uninjured sciatic nerves of c-Jun OE/ and
OE/OEmice. Consistentwith themRNAdata, Krox20 levelswere
essentially unaffected in c-Jun OE/ mice both in double-label
immunohistochemical experiments, which show Krox20 in
Schwann cell nuclei, and in Western blotting experiments (Fig.
3D,E).Mpz levels in thesemicewere15% lower than those found
in WT mice (Fig. 3F). In contrast, the c-Jun OE/OE mice ex-
pressed significantly less Krox20 protein in Schwann cell nuclei
and Western blots (Fig. 3D,E) and much reduced levels of Mpz
(Fig. 3F).
This indicates that, in adult-JunOE/ nerves, the levels of key
myelin-related proteins and theirmRNA remain relativelymildly
affected despite 6-fold elevation of Schwann cell c-Jun. This
tolerance does, however, break down when c-Jun levels are ele-
vated28-fold, as seen in c-JunOE/OEmice, which is consistent
with the capacity of c-Jun to regulate myelin genes negatively as
indicated in in vitro experiments and in mice with conditional
inactivation of Schwann cell c-Jun (Parkinson et al., 2004, 2008;
Arthur-Farraj et al., 2012).
4
(Figure legend continued.) P300WT (n 4) and OE/ (n 5) nerves. Mann–Whitney U test:
p 0.4444.P, The numbers ofmyelinated axons per nerve profile is similar in P300WT (n 4)
andOE/ (n 5) nerves.Mann–WhitneyU test: p 0.1905.Q, Per nerve profile, the number
of axons that are
1.5 m in diameter and in a 1:1 relationship but not myelinated is not
significantly different between P300WT (n 4) and OE/ (n 5) nerves. Mann–Whitney U
test: p 0.4444.R, Measured by g-ratios,myelin is thinner in P300 OE/ (n 5) nerves than
inWT (n4). Thewhiskers extend from the5th to the 95thpercentiles.Mann–WhitneyU test:
p 0.0079. S, The percentage of unmyelinated axons
1.5m in diameter that remain in
Remak bundles is similar in P300WT (n 4) andOE/ (n 5) nerves.Mann–WhitneyU test:
p
 0.9999.
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Figure 5. High c-Jun levels in c-Jun OE/OE nerves result in hypomyelination. A, Electron micrographs showing lack of myelin and increased connective tissue spaces in P60 c-Jun OE/OE nerves
comparedwithWT.B, The total number of axons larger than 1.5mindiameter is not significantly different in P60WT (n 5) and c-JunOE/OE (n 3) nerves.Mann–WhitneyU test: p 0.0714.
C, The percentage of axons in a 1: 1 relationship and
1.5m in diameter that are myelinated is lower in c-Jun OE/OEmice than inWT (n 5) and OE/OE (n 3) nerves. Mann–Whitney U test:
p 0.0179.D, The number ofmyelinated axons per nerve profile is substantially reduced in c-JunOE/OE (n 3) nerves comparedwithWT (n 5).Mann–WhitneyU test: p 0.0357. E, Per nerve
profile, the number of axons in a 1:1 relationship and
1.5m in diameter but not myelinated is much higher in OE/OE (n 3) nerves than in WT (n 5). Mann–Whitney U test: p 0.0179.
F, Myelin, measured as g-ratios, is thinner in OE/OE (n 3) mice compared withWT (n 5). The whiskers extend from the 5th to the 95th percentiles. Mann–Whitney U test: p 0.0357. G, The
percentage of unmyelinated axons
1.5m in diameter that remain in Remak bundles is higher in OE/OE (n 3) nerves than inWT (n 5) nerves.Mann–WhitneyU test: p 0.0357.H, Nerves
in c-Jun OE/OEmice (n 3) contain more mast cells that nerves inWTmice (n 5). Mann–Whitney U test: p 0.0179. I, OE/OE (n 3) nerves showmore Schwann cell nuclei per nerve profile
thanWT (n5)nerves.Mann–WhitneyU test:p0.0357. J,Westernblot of sciatic nerveprotein extracts fromP60mice.Note that levels of cyclinD1 (amarker of cell proliferation) are significantly
higher inOE/OEnerves than inWTorOE/ornerves. The results arequantified in thegraph.WT,n5;OE/,n4; andOE/OE,n5. Thequantifications arenormalized to the levels inuninjured
WT nerves, which are set as 1. One-way ANOVA with Tukey’s comparison: *p  0.05, **p  0.01. K, Counts of Ki67-positive/Sox10-positive nuclei indicate (Figure legend continues.)
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Structure of adult nerves is nearly normal in c-Jun OE/mice
Although the levels of myelin proteins were normal in c-Jun
OE/mice, it remained possible that the substantial c-Jun eleva-
tion affected myelination and nerve architecture. This was tested
by a morphometric comparison of WT and c-Jun OE/ nerves.
The general appearance of WT and c-Jun OE/ nerves of
60-d-old mice was similar (Fig. 4A). The size of the cross-sec-
tional profiles of the sciatic nerve and the number of Schwann cell
nuclei were not significantly different between the two genotypes
and Ki67 labeling of Sox10-positive cells failed to show a signifi-
cant increase in Schwann cell proliferation (Fig. 4B–D). WT and
c-Jun OE/ nerves had similar numbers of 
1.5 m axons per
nerve profile and the percentage of segregated (1:1), myelin-
competent (
1.5 m diameter) axons that were myelinated and
the total number of myelinated axons were comparable (Fig. 4E–
G). BothWT and c-Jun OE/ nerves contained similar, very low
numbers of myelin-competent (
1.5 m diameter) axons in a
1:1 relationship that remainedunmyelinated (Fig. 4H).Measure-
ments of g-ratios showed that myelin sheaths were slightly thin-
ner in c-Jun OE/ mice compared with WT (Fig. 4I). Remak
bundles in c-Jun OE/ mice appeared normal and the percent-
age of
1.5maxons thatwere foundwithinRemakbundleswas
similar and very low in both genotypes (Fig. 4J).
We found that this similarity between WT and c-Jun-over-
expressing c-Jun OE/ 60-d-old mice remained even in old (300
d) mice (Fig. 4K–S). As in young mice, observations of general
appearance and quantitative analysis failed to reveal significant
differences between the two genotypes, except for the difference
in G-ratios, a difference that was also seen in young mice (Fig.
4R). The only age-induced change related to Schwann cell
numbers, which were somewhat elevated in old mice, with the
difference between the genotypes reaching statistical signifi-
cance (Fig. 4M ).
These observations show that, although c-Jun OE/ mice
show 6-fold elevation of c-Jun protein that is localized to
Schwann cell nuclei, they achieve essentially normal Schwann cell
and nerve architecture, with the exception of modestly reduced
myelin thickness.
Adult nerves of c-Jun OE/OEmice are hypomyelinated and
show onion bulbs and hyperplasia but do not form tumors
In contrast to c-Jun OE/ mice, the higher (28-fold) c-Jun
expression in c-JunOE/OEmice resulted in obvious lack ofmyelin
in 60-d-old mice (Fig. 5A). Although the total number 
1.5 m
axons was similar to WT (Fig. 5B), the percentage of segregated
(1:1), myelin-competent (
1.5 m diameter) axons that were
myelinated was reduced by40% (Fig. 5C) and there was a cor-
responding increase in the number of myelin-competent axons
that that had reached a 1:1 relationship but remained unmyeli-
nated (Fig. 5E). The myelin sheaths in c-Jun OE/OE mice were
also thin compared with WT (Fig. 5F). Although all of this indi-
cates an impediment to myelination, a sorting defect was indi-
cated by the fact that the percentage of 
1.5 m axons that
remained within Remak bundles was strikingly increased to
28% compared with 1% in WT (Fig. 5G). As a result of im-
paired myelination and sorting, the number of myelinated axons
in c-JunOE/OEnerves was substantially lower than inWTnerves
(Fig. 5D). As seen in mouse models of CMT1A neuropathy and a
number of other mouse mutants with elevated, nontumorigenic
Schwann cell proliferation, the organization of Remak bundles
was somewhat altered (Robertson et al., 2002; Chen et al., 2003;
Ling et al., 2005; Verhamme et al., 2011). The cells sometimes
showed increased membranous structures and processes that were
not in contact with axons and they contained fewer axons per
transverse section of a bundle, suggesting the presence of a larger
number of Remak cells each taking care of fewer axons (Fig. 5A).
Increasedmast cell numbers are seen in several neuropathic con-
ditions and mutant models and after mechanical nerve injury
(Olsson, 1971; Ling et al., 2005; Ishii et al., 2016). We therefore
counted mast cell numbers and found substantial elevation in
c-Jun OE/OE nerves (Fig. 5H).
An increase in Schwann cell number, a feature of many neu-
ropathies including CMT1A (Robertson et al., 2002; Lupski and
Chance, 2005), was also seen in c-Jun OE/OE nerves, the total
number of Schwann cell nuclei per nerve profile being 6-fold
that inWT (Fig. 5I). Western blots of Cyclin D1 indicated ongo-
ing proliferation among the cells of c-JunOE/OEnerves (Fig. 5J).
Proliferation of Schwann cells was indicated in double immunola-
beling with Ki67 and Sox10 antibodies to detect dividing Schwann
cells because double labeled Schwann cells, although few, were
3more common in c-Jun OE/OE nerves than in WT nerves
(Fig. 5K). Observations in the electron microscope provided no
evidence for the presence of a significant number of Schwann cells
without contact with axons. The increased number of Schwann cell
nuclei in nerve sections is likely due to non-myelinating cells in a 1:1
ratio, with axons being shorter thanmyelin cells, cells with thinmy-
elin sheaths being shorter than those with normal sheath thickness,
and an increased number of Remak cells.
The sciatic nerves of 60-d-old c-Jun OE/OE mice were en-
larged, showing total cross-sectional profiles that were2 that
in c-Jun OE/ or WT nerves (Fig. 5L). Collagen containing ex-
tracellular space was also markedly increased in c-Jun OE/OE
nerves, occupying 133,349 m2 (	19,891; n  3; 54% of nerve
area) in 60 d c-Jun OE/OE nerves, but only 16,069 m2 (	2834;
n 5; 13% of nerve area) inWT nerves (Fig. 4M). This amounts
to an increase in extracellular space of 116,280 m2. Because the
nerves of c-Jun OE/OE nerves are 121,486 m2 larger than WT
nerves,
95% of the enlargement seen in c-Jun OE/OE nerves is
due to increased collagen-containing extracellular space, with a
likely contribution from increased number of Remak cells and
cells other than Schwann cells. Increase in endoneurial connective
tissue is seen inanumberofneuropathies, includingCMT1A,and in
the trembler and twitchermousemutants (Low, 1977; Palumbo et
al., 2002; Ling et al., 2005; Kagitani-Shimono et al., 2008; Fledrich
et al., 2012).
We examined the mutant nerves extensively for the presence
of tumors or cellular arrangements reminiscent of tumor forma-
tion, but failed to find any evidence for either. Consistent with
this, the tumor suppressor p19ARF was strongly elevated in unin-
jured nerves of c-Jun OE/EO mice (Fig. 5N).
Examination of old (P300)mice showed that only three of the
parameters studied above changed obviously with age (Fig. 6A–J):
(1) the appearance of significant numbers of onion bulbs (Fig.
6F,G); (2) a reduction in Schwann cell proliferation, which was
4
(Figure legend continued.) a higher rate of Schwann cell proliferation in c-Jun OE/OEmice (n
5) compared with WT (n 3). Mann–Whitney U test: p 0.0179. L, The area of transverse
profiles of OE/OE (n 3) nerves is larger than ofWTnerves.Mann–WhitneyU test: p 0.0357
(n 5).M, Tracing of cell profiles and extracellular space (ECM) in transverse nerve sections,
followed by areameasurements, shows a relative increase in extracellular space in OE/OE (n
3) nerves compared with WT (n 5). Mann–Whitney U test: p 0.0357. N, Western blot of
sciatic nerve protein extracts fromP60mice. Note increased expression of the tumor suppressor
p19ARF. The results are quantified in the graph. The quantifications are normalized to the levels
in uninjured WT nerves, which are set as 1. One-way ANOVA with Tukey’s comparison: *p
0.05 (n 3).
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no longer significantly elevated (Fig. 6J); and (3) a reduction in
the percentage of 
1.5 m axons that remained within Remak
bundles, from28% at P60 (Fig. 5G) to2% (Fig. 6E). There-
fore, in nerves of c-Jun OE/OE mice, a large number of axons
appear to segregate gradually from Remak bundles between P60
and P300. The proportion of these
1.5maxons thatmyelinate
is similar to that of the
1.5 m segregated axons in P60 nerves:
60% (Fig. 6B). No tumors were found in older mice (n 18).
Developmental myelination is delayed in c-Jun OE/mice
but inhibited in c-Jun OE/OE mice
Although adult nerves of c-Jun OE/ mice are essentially nor-
mal, we tested whether the c-Jun elevation in these nerves caused
a delay in myelination during development. We also determined
whether the lack of myelin in the adult c-Jun OE/OE nerves was
due to demyelination in the adult or inhibition of myelination
during development.
In developing nerves of c-Jun OE/ mice, there was a trend
toward c-Jun elevation at P1, but this was not significant, whereas at
P7, Junwas elevated6-fold comparedwithWTnerves at the same
age. This failed to suppress levels of the myelin proteins Mpz and
Krox20 inWestern blots (Fig. 7A,B). However, nuclear Krox20was
reduced, as shown by double labeling of nerve sections with Krox20
and Sox10 antibodies to identify Schwann cells (Fig. 7C).
In developing nerves of c-Jun OE/OE mice, c-Jun levels at P7
were8-fold that found inWTmice at that age andMpz was sup-
pressed inWestern blots (Fig. 7A). AlthoughKrox20 levels were not
significantly reduced inWestern blots, the number of Schwann cells
that showednuclearKrox20was50%of that inWTnerves, as seen
in double immunolabeling of nerve sections (Figure 7B,C).
Figure 6. Nerves of aged c-Jun OE/OEmice. A, The nerves of P300 c-Jun OE/OEmice andWTmice contain comparable numbers of axons. Mann–Whitney U test: p 0.1143 (n 4). B, In P300
c-JunOE/OEmice, the percentage of axons in a 1: 1 relationship and
1.5mindiameter that aremyelinated is lower than inWTmice.Mann–WhitneyU test: p 0.0286 (n 4). C, In P300 c-Jun
OE/OEmice, the number of myelinated axons per nerve profile is reduced compared withWT. Mann–Whitney U test: p 0.0286 (n 4).D, Per nerve profile, P300 c-Jun OE/OEmice have amuch
larger number of unmyelinated axons that are
1.5m in diameter and in a 1:1 relationship and compared with WT mice. Mann–Whitney U test: p 0.0286 (n 4). E, The percentage of
unmyelinated axons
1.5m in diameter that are foundwithin Remak bundles is higher in OE/OE nerves than inWT nerves. Mann–Whitney U test: p 0.0286 (n 4). F, Electronmicrographs
from nerves of P300 c-Jun OE/OE mice showing examples of onion bulbs. The central axon, which is sometimes myelinated (top), is surrounded by relatively few layers of flattened Schwann cells,
suggesting an early stage of bulb formation. Scale bar, 1m. G, The number of onion bulbs in P300 OE/OE nerves is much higher than in WT nerves. Mann–Whitney U test: p 0.0286 (n 4).
H, P300OE/OEnerves contain ahigher number ofmast cells thanWTnerves.Mann–WhitneyU test:p0.0286 (n4). I, Nerves in P300 c-JunOE/OEmice showmore Schwann cell nuclei per nerve
profile than nerves inWTmice. Mann–Whitney U test: p 0.0286 (n 4). J, The rate of Schwann cell proliferation is not significantly higher in P300 OE/OE nerves than inWT nerves, as shown by
the counts of Ki67-positive/Sox10-positive nuclei. Mann–Whitney U test: p 0.1000 (n 3).
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Figure 7. Developmental overexpression of c-Jun delays myelination in c-Jun OE/mice, but inhibits myelination in c-Jun OE/OEmice. A, Western blot of nerve extracts from P1 and P7 sciatic
nerves. The results are quantified in the graphs. Data fromP1nerves are normalized to levels in P1WTnerve,which are set as 1,whereas data fromP7nerves are normalized to levels in P7WTnerve,
which are set as 1. Note that, by P7, c-Jun is elevated in both OE/ and OE/OE nerves, whereasMpz is reduced in OE/OE nerves only. P1WT, n 3; OE/, n 3; P7WT, n 4; OE/, n 4; and
OE/OE, n 3. Statistical analysis for P1 is Student‘s t test: p 0.0608 for c-Jun, p 0.0174 forMpz. Statistical analysis for P7 is one-way ANOVAwith Tukey’s comparison: *p 0.05, **p 0.01,
****p 0.0001. B, Western blot of nerve extracts from P7WT, OE/, and OE/OE nerves. The results are quantified in the graph. Krox20 levels are similar in all genotypes. One-way ANOVA with
Tukey’s comparison: p 0.2053 (n 3). C, The percentage of Krox20/Sox10-positive Schwann cells in sections fromWT (n 8), OE/ (n 6), and OE/OE (n 3) sciatic nerves at P7. Note a
graded decrease in Krox20-positive cells as levels of c-Jun increase. One-way ANOVAwith Tukey’s comparison: *p 0.05, ***p 0.001. D, Representative electronmicrographs from P1, P7, and
P21 nerves ofWT, c-Jun OE/, and c-Jun OE/OEmice. Note hypomyelination in OE/OE nerve at P7 and P21 and transient hypomyelination in OE/ nerves at P7. Scale bar, 5m. E, The nerve areas
are similar in all three genotypes at all developmental stages. One-wayANOVAwith Tukey’s comparison: P1WT (n 5), OE/ (n 4), andOE/OE (n 5), p 0.1978; P7WT (n 5), OE/ (n
5), and OE/OE (n 3), p 0.2261; and P21WT (n 5), OE/ (n 4), and OE/OE (n 4), p 0.084. F, The number of Schwann cell nuclei per sciatic nerve profile at P1, P7, and P21 in nerves
ofWT, c-Jun OE/, and c-Jun OE/OEmice. Note the transient difference betweenWT and OE/ nerves at P7, whereas OE/OE nerves havemore Schwann cells at P7 and P21. P1WT, n 5; OE/,
n  4; and OE/OE, n  5; P7 WT, n  5; OE/, n  5; and OE/OE, n  3; and P21 WT, n  5; OE/, n  4; and OE/OE, n  4. One-way ANOVA with (Figure legend continues.)
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Electron microscopy at P1, P7, and P21 showed that, in c-Jun
OE/ mice, myelination was transiently delayed at P7, whereas in
c-Jun OE/OEmice, myelination was severely inhibited (Fig. 7D).
In c-Jun OE/mice, nerve area and the percentage of
1.5-
m-diameter axons thatwere foundwithin Schwann cell families
or Remak bundles, both of which were normal in the adult, were
also normal during development at all 3 time points (Fig. 7E,K).
However, a number of other parameters were abnormal at P7,
although they were normal at P1 and P21, revealing a transient
delay in myelination. This includes the number of Schwann cell
nuclei, which was elevated (Fig. 7F); the percentage of segregated
(1:1), myelin-competent (
1.5 m diameter) axons that were
myelinated, which was reduced; the total number of myelinated
axons, which was reduced (Fig. 7H); and the number of segre-
gated (1:1) myelin-competent (
1.5 m diameter) axons that
were notmyelinated, whichwas elevated (Fig. 7I). In adult nerves
of thesemice, themyelin sheathswere slightly thinner than inWT
and this difference was already present at P7 and P21 (Fig. 7J).
In the developing c-Jun OE/OE nerves, nerve area was not
significantly different from that seen in WT or c-Jun OE/mice
(Fig. 7E). The large nerve area in P60 nerves of these mice there-
fore emerges in adulthood. At P7 and P21, these nerves contained
2 the number of Schwann cell nuclei seen in WT nerves, a
smaller difference than that seen in the adult (Fig. 7F). This sug-
gests ongoing, low-level Schwann cell proliferation in adult
mutant nerves, supported by Ki67 labeling of Sox10-positive
Schwann cells, although the differences between WT and c-Jun
OE/OE nerves in cyclin D1 levels and did not reach significance
(Fig. 7L,M). In other respects, the differences between developing
WTandmutant nerves at P7 andP21 alreadymatched those seen in
adult P60 nerves. This includes a reduced number of myelinated
axons, an increased number of segregated myelin competent axons
that remained unmyelinated, thinner myelin sheaths, and an in-
creased number of
1.5-m-diameter axons that were seen within
Schwann cell families or Remak bundles (Fig. 6G–K).
These experiments show that c-Jun negatively regulates devel-
opmental myelination in a dose-dependent manner. In the c-Jun
OE/mouse,6-fold overexpression of c-Jun results in a tran-
sient delay at P7, whereas the nerve had recovered at P21. Con-
versely, in the developing nerves of c-Jun OE/OE mice, in which
c-Jun levels are50% higher than in c-Jun OE/ nerves, myeli-
nation is permanently inhibited and seen in only 30–40% of

1.5-m-diameter myelin-competent axons, a figure compara-
ble to that seen in the adult.
Remyelination after nerve injury in c-Jun OE/mice
c-Jun is a key amplifier of the repair Schwann cell phenotype,
which is generated in the distal stump of injured nerves. There-
fore, elevation of c-Jun is a candidate approach for improving
nerve repair under conditions where it falters, such as in older
animals or due to long-term Schwann cell denervation (Wagstaff
et al., 2017). The observation that, in c-Jun OE/ mice, adult
nerveswith6-fold elevation of c-Jun achieve a relatively normal
degree of nerve architecture and myelination during develop-
ment, albeit with a delay, is encouraging for this approach
because it demonstrates that significant c-Jun elevation and my-
elination are compatible. However, after injury, remyelination is
slower and more easily disrupted than developmental myelina-
tion. The two processes are also partly controlled by distinct sig-
nals. We therefore tested the capacity of c-Jun OE/ nerves to
remyelinate after nerve injury.
After sciatic nerve crush injury, c-Jun levels distal to the crush
were elevated in WT mice and this elevation was enhanced in
c-Jun OE/ mice, as expected (Fig. 8A). At 1, 7, and 14 d after
injury, c-Jun levels in OE/ nerves were 2- to 3-fold higher than
those in crushed WT control nerves. This amounted to an12-
fold (at 1 d after crush) to an30-fold (at 7 and 14 d after crush)
elevation of c-Jun in crushed c-Jun OE/ nerves compared with
the levels found in uninjured control nerves. This was accompa-
nied by somewhat lower Krox20 levels (Fig. 8B). At 21 d after
crush, c-Jun levels in WT nerves had declined, although they
remained significantly above those in uninjured nerves (data not
shown).
When examined 4 d after nerve cut, nerves of c-Jun OE/
mice showed accelerated collapse/breakdown of myelin sheaths
and faster clearance of the myelin protein MBP, in agreement
with previous evidence that c-Jun promotesmyelin clearance and
myelin autophagy (Arthur-Farraj et al., 2012; Gomez-Sanchez et
al., 2015) (Fig. 8C,D).
Examination of crushed c-Jun OE/ nerves by electron mi-
croscopy showed a significant delay in remyelination at 2 weeks
after nerve crush (Fig. 8E). At this time point,35% of myelin-
competent (
1,5 m) axons were myelinated in OE/ nerves,
whereas 
95% were myelinated in WT nerves (Fig. 8F ). At 2
weeks after crush, the number of myelinated axons was also re-
duced in OE/ nerves (Fig. 8G) and the number of segregated,
myelin-competent axons without myelin was elevated (Fig. 8H).
Significant recovery was seen 4 weeks after crush, when75% of
myelin-competent axons were myelinated in OE/ nerves com-
paredwith 98% inWTnerves. By 10weeks, essentially allmyelin-
competent axons were myelinated in both genotypes, a situation
similar to that in uninjured nerves of these mice (Fig. 8E–H).
Myelin sheaths in adult c-JunOE/mice are thinner than inWT
4
(Figure legend continued.) Tukey’s comparison: **p 0.01, ***p 0.001, ****p 0.0001.
G, The percentage of axons in a 1:1 relationship and
1.5m in diameter that aremyelinated
at P1, P7, and P21 in nerves of WT, c-Jun OE/, and c-Jun OE/OEmice. Note reducedmyelina-
tion in OE/OE mice at P7 and P21 and transient reduction in OE/mice at P7. P1 WT, n 5;
OE/, n 4; and OE/OE, n 5; P7WT, n 5; OE/, n 5; and OE/OE, n 3; and P21WT,
n 5; OE/, n 4; and OE/OE, n 4;. One-way ANOVA with Tukey’s comparison: **p
0.01 and ***p 0.001.H, The number ofmyelinated axons per nerve profile at P1, P7, andP21
in nerves of WT, c-Jun OE/, and c-Jun OE/OE mice. Note the substantial reduction in myelin-
ated axons in OE/OE nerves at P7 and P21 and transient decrease in OE/mice at P7. P1 WT,
n 5; OE/, n 4; and OE/OE, n 5; P7WT, n 5; OE/, n 5; and OE/OE, n 3; and
P21 WT, n 5; OE/, n 4; and OE/OE, n 4;. One-way ANOVA with Tukey’s comparison:
*p 0.05, **p 0.01, ***p 0.001, ****p 0.0001. I, The number of axons in a 1:1
relationship and
1.5m in diameter that remain unmyelinated at P1, P7, and P21 in nerves
of WT, c-Jun OE/, and c-Jun OE/OE mice. Note the increase in unmyelinated axons in OE/OE
nerves at P7andP21, but at P7only inOE/mice. P1WT,n5;OE/,n4; andOE/OE,n
5; P7WT,n5;OE/,n5; andOE/OE,n3; andP21WT,n5;OE/,n4; andOE/OE,
n  4. One-way ANOVA with Tukey’s comparison: **p  0.01, ***p  0.001, ****p 
0.0001. J, Reduction in myelin thickness, measured as g-ratios, which is seen in the adults in
bothOE/andOE/OEnerves, is alreadypresent atP7andP21.P7WT,n5;OE/,n5; and
OE/OE, n 3; and P21WT, n 5; OE/, n 4; and OE/OE, n 4. Thewhiskers extend from
the 5th to the 95th percentiles. One-way ANOVA with Tukey’s comparison: *p 0.05, **p
0.01, ***p 0.001. K, The percentage of unmyelinated axons that are
1.5m in diameter
in Schwann cell families or Remak bundles at P1, P7, and P21 in nerves ofWT, c-Jun OE/, and
c-Jun OE/OE mice. Abnormally high numbers are seen in OE/OE nerves only. P1 WT, n 5;
OE/, n 4; and OE/OE, n 5; P7WT, n 5; OE/, n 5; and OE/OE, n 3; and P21WT,
n 5; OE/, n 4; andOE/OE, n 4. One-wayANOVAwith Tukey’s comparison: *p 0.05,
**p 0.01, ***p 0.001. L, Western blot of nerve extracts from P7WT (n 3), OE/ (n
3), and OE/OE (n 3) sciatic nerves showing cyclin D1, an indicator of cell proliferation. Quan-
tification of the data are normalized to levels in P7WT nerve, which are set as 1. Cyclin D1 levels
are similar in allmouse lines. One-wayANOVAwith Tukey’s comparison:p0.3871.M, Counts
of Ki67-positive/Sox10-positive nuclei in P7 inWT (n 6), OE/ (n 6), and OE/OE (n 3)
nerves. OE/OE nerves show increased Schwann cell proliferation. One-way ANOVAwith Tukey’s
comparisons: *p 00121. In E–K, p-values are calculated relative to WT at the same age.
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Figure8. RemyelinationofOE/nerves is delayed. A,Westernblot of c-Jun innerveextracts fromthedistal stumpof adultWT (n4) andOE/ (n4)nerves 1d, 7d, and2weeks after crush.
The graph shows quantification of the results normalized to levels in uninjuredWT nerves, which are set as 1. Note significant elevation of c-Jun at all time points. Mann–Whitney U test: 1 d, p
0.0006 (n 4); 7 d, p 0.0002 (n 4); and 2 weeks, p 0.0022 (n 4). B, Western blot of nerve extracts from the distal stump of adult WT and OE/ nerves 2 weeks after crush. The results
are quantified in the graph and normalized to levels in 2 week crushed WT nerve, which are set as 1. Krox20 levels are reduced in OE/ nerves. Mann–Whitney U test: p 0.0286 (n 4).
C, Representative electronmicrographs from the distal stump 4 d after sciatic nerve cut inWT and c-Jun OE/mice illustrating collapsedmyelin sheaths. The graph shows that fewer intact myelin
sheaths per nerve profile remain in OE/ nerves than in WT. Mann–Whitney U test: p 0.0286 (n 4). D, Transected c-Jun OE/ nerves clear myelin protein faster thanWT nerves. The graph
shows the reduction in MBP 4 d after transection expressed as a percentage of MBP in uninjured nerve. WT and c-Jun OE/ nerves have cleared close to 40% and 60% of their MBP content,
respectively. The data are obtained fromquantitation ofWestern blots.WT, n 4; OE/, n 8.Mann–WhitneyU test: p 0.0070. E, Representative electronmicrographs from the distal stump
of WT and OE/ nerves 2, 4, and 10 weeks after crush. In OE/ nerves, the number of myelinated axons, which is reduced at 2 and 4 weeks, has recovered at 10 weeks. Scale bar, 5m. F, The
percentage of axons
1.5mindiameter and in a 1:1 ratio that aremyelinated in the distal stumpofWT and c-JunOE/mice 2, 4, and 10weeks after nerve crush. Note thatmyelination in OE/
nerves, which is reduced at 2 weeks, has recovered substantially by 4 weeks and is normal at 10 weeks. Mann–Whitney U test: 2 weeks, p 0.0286 (n 4); 4 weeks, p 0.0079 (n 5); and 10
weeks, p  0.0571 (n  4). G, The number of myelinated axons per nerve profile of the distal stump of WT and c-Jun OE/ mice 2, 4, and 10 weeks (Figure legend continues.)
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(see previous section) and this difference was also seen in remy-
elinated nerves (Fig. 8I). Tumors were not seen and regenerating
WTand c-JunOE/nerves did not differ in size (Fig. 8J) or other
aspects of general nerve architecture (Fig. 8E).
Importantly, the c-Jun OE/ mice achieved full functional
recovery after nerve crush. In the toe pinch test, which is primar-
ily a sensory test, time to full recovery was comparable inWT and
c-Jun OE/ mice, whereas time to initial response (group aver-
age)was2 d longer in themutants (Fig. 9A,B). In the toe spread
reflex, primarily a test of motor recovery, c-Jun OE/ mice
showed a transient delay in recovery on days 14 and 15 only (Fig.
9C), possibly caused by delay in myelination at this time point
(Fig. 8F,G). In the sciatic functional index, a sensory–motor test,
c-Jun OE/ mice showed a nonsignificant trend toward a tran-
sient delay during the second and third week after injury (Fig.
9D,E).
Discussion
We have generated c-Jun OE/ and c-Jun OE/OE mice with
forced expression of c-Jun in Schwann cell nuclei to study the
effects of a graded increase in c-Jun expression on Schwann cell
development and on remyelination after injury. First, we have
shown that, during development and in adult nerves, Schwann
cells are remarkably tolerant of elevated c-Jun levels. Although
developing and adult nerves of c-Jun OE/mice showed an6-
fold increase in c-Jun relative to WT nerves at the same age,
myelination is only transiently affected at P7. By P21, myelina-
tion appears normal and, in the adult, Schwann cells and nerve
architecture are similar to that in WT nerves, with the exception
of modestly reduced myelin thickness, which is unlikely to have
significant consequences for sensory–motor control. Second, al-
though remyelination after injury, which generally is more easily
perturbed than in development, is delayed in c-Jun OE/mice,
remyelination shows strong recovery at 4weeks and essentially all
myelin-competent axons are myelinated at 10 weeks after injury.
As in uninjured nerves, the myelin sheaths of regenerated OE/
nerves remain thinner than those in regeneratedWT nerves. The
sensory and motor tests used here show only a slight delay fol-
lowed by complete functional recovery in c-Jun OE/ mice.
Therefore, the c-Jun elevation in c-Jun OE/mice is compatible
with essentially normal restoration of myelin and nerve function
similar to that found before injury. This is important because we
find that the c-Jun elevation in c-Jun OE/ mice is sufficient to
accelerate regeneration under conditions in which it is compro-
mised by aging or long-term denervation (Wagstaff et al., 2017;
L.J. Wagstaff, J. Gomez-Sanchez, R. Mirsky, and K.R. Jessen, un-
published data). Third, the higher overexpression achieved in
c-Jun OE/OE mice confirms the potential of c-Jun to negatively
regulate myelination, as seen previously in vitro. Myelination is
strongly impaired during development and this persists in adult
nerves, which show hypomyelinating pathology, enlarged con-
nective tissue, and immature onion bulbs. Fourth, even in nerves
of aged c-Jun OE/OEmice, there is no evidence of tumor forma-
tion and these nerves show strong activation of the tumor sup-
pressor P19ARF. The absence of tumorigenic effect of enforced
c-Jun expression in Schwann cells is in agreement with the fact
that mechanical nerve damage is not associated with tumor for-
mation, although injured WT nerves contain proliferating cells
with high c-Jun levels.
c-Jun is involved directly or indirectly in the control of180
of the 4000 genes that change significantly after nerve injury.
This allows c-Jun to take part in the regulation of a spectrum of
properties of denervated repair Schwann cells, including
morphology, autophagy-mediated myelin breakdown, and the
expression of trophic factors linked to regeneration, including
GDNF, artemin, BDNF, NGF, and LIF (Eggers et al. 2010;
Arthur-Farraj et al., 2012; Fontana et al., 2012; Gomez-Sanchez et
al., 2015, Jessen and Mirsky, 2016; Jessen et al., 2015a). Of these,
GDNF, artemin, and LIF have been shown to be direct targets of
c-Jun. Additional evidence for direct regulation of injury-induced
genes by c-Jun comes from a study of enhancer activation in
Schwann cells. This showed c-Jun-binding sites associated with
injury-activated enhancers of genes elevated after nerve injury,
including Shh, Olig1, and Runx2 (Hung et al., 2015).
The gene targets and function of AP-1 transcription factors, a
family to which c-Jun belongs, are regulated by dimerization part-
ners and ancillary proteins (Chinenov and Kerrpola, 2001; Eferl
and Wagner, 2003). Little is known about these components in
Schwann cells.
RNA sequencing analysis showed that, in uninjured nerves of
c-Jun OE/mice, 95 genes were expressed at levels that differed
2-fold from those inWTnerves. Sixty-seven of these geneswere
upregulated in response to increased c-Jun levels including Shh.
In c-Jun OE/OE nerves, 1964 genes were changed 2-fold and
909 of these were upregulated, among them GDNF, Shh, Olig1,
Id2, Sox2, and Runx2. The myelin genes Mpz, Mbp, and Pmp22
were all strongly downregulated in c-Jun OE/OE nerves. Exam-
ining injured nerves, we previously identified 172 genes that were
expressed at different levels in 7 d cut nerves ofmice, in which c-Jun
was genetically inactivated compared with inured WT nerves. Of
these 172 genes, 106 were upregulated by higher c-Jun levels,
namely expressedmore highly in cutWTnerves than in cut c-Jun
knock-out nerves. A comparison of the 15 genes most upregu-
lated by c-Jun in uninjured c-JunOE/ andOE/OE nerves in the
present work with the 15 genes that are most upregulated by
c-Jun in 7 d cut nerves reveals only two common genes, Shh and
GDNF. This limited similarity indicates that the group of genes
directly or indirectly regulated by c-Jun in Schwann cells that have
adopted the repair phenotype after injury is significantly different
from the set of genes, which responds to c-Jun in cells that ensheath
axons, many of which retain myelin differentiation.
We find that the substantial c-Jun elevation in c-Jun OE/OE
mice is sufficient to cause severe hypomyelination. This is un-
doubtedly related to the ability of c-Jun to suppressmyelin genes.
Although the causal relationship between the increased c-Jun
levels seen in human CMT1A and demyelination has not been
analyzed (Hutton et al., 2011), it seems clear that sustained dys-
regulation of c-Jun resulting in high expression in uninjured
nerves is a potential hazard. c-Jun is therefore a candidate for a
factor that could cause or promote pathological demyelination.
4
(Figure legend continued.) after nerve crush. In c-Jun OE/ mice, few myelinated axons are
present at 2weeks, but normal numbers are seen at 10weeks. Mann–WhitneyU test: 2weeks,
p 0.0286 (n 4); 4 weeks, p 0.0079 (n 5); and 10weeks, p 0.0571 (n 4).H, The
number of unmyelinated axons
1.5m in diameter and in a 1:1 relationship that have not
myelinated in the distal stump ofWT and OE/ nerves 2, 4, and 10weeks after crush. Two and
4 week crushed OE/ nerves contain elevated numbers of umyelinated axons, but their num-
ber has fallen to normal levels at 10 weeks. Mann–Whitney U test: 2 weeks, p 0.0286 (n
4); 4 weeks, p 0.0079 (n 5); and 10 weeks, p 0.1143 (n 4). I, Myelin thickness,
measured as g-ratios, is reduced in the distal stump of OE/ nerves at all time points after
crush. The whiskers extend from the 5th to the 95th percentiles. Mann–Whitney U test: 2
weeks, p 0.0286 (n 4); 4weeks, p 0.0079 (n 5); and 10weeks, p 0.0286 (n 4).
J, The area of transverse sections through the distal stump 2, 4, and 10 weeks after crush is
similar inWT and OE/ nerves. Mann–WhitneyU test: 2weeks, p 0.6571 (n 4); 4weeks,
p 0.3095 (n 5); and 10weeks, p 0.9004 (n 4). In A and F–J, p-values are calculated
relative to WT at the same time after injury.
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c-Jun OE/OE nerves and nerves affected by demyelinating
neuropathies, in particular CMT1A, show many similarities, most
obviously hypomyelination. In c-Jun OE /OE mice, this involves
substantially thinner myelin sheaths and an 40% reduction in
myelination among axons that have segregated and are myelin
competent. Axonal sorting is also adversely affected in younger
(P60) c-JunOE/OEmice because, in thesemice, the percentage of
unsorted 
1.5-m-diameter axons that remain in Remak bun-
dles is 28% comparedwith1% inWT. In commonwith human
CMT1Anerves and nerves of theC22 andMy41mousemodels of
CMT1A, c-Jun OE/OE nerves also contain increased Schwann
cell numbers (Robertson et al., 2002; Lupski and Chance, 2005).
However, neither mousemodels of CMT1A nor the c-JunOE/OE
mice show a significant numbers of Schwann cells that are without
axonal contact. Increase in endoneurial connective tissue, which is
substantial in c-JunOE/OEmice, is also a feature of humanCMT1A
Figure 9. Functional recovery is slightly delayed in c-Jun OE/mice.A, Toe pinch assay showing the percentage ofmice that showa response to a pinch of toes 3, 4, and 5 at different times after
sciatic nerve crush in WT and c-Jun OE/mice. In c-Jun OE/mice, all toes show a trend toward a delayed response. B, The average time in days after crush at which the first toe pinch response
is seen in toes 3, 4, and 5.WT, n 10; OE/, n 9. Mann–Whitney U test: p-values are calculated relative toWT for each toe. Toe 3, p 0.0056; toe 4, p 0.0043; toe 5, p 0.0404. C, The toe
spread reflex in WT (n 10) and OE/ (n 9) mice after sciatic nerve crush. The reflex response is delayed at days 12, 14, and 15 in c-Jun OE/ mice. Two-way ANOVA with Bonferroni’s
comparison: p 0.0171.D, Representative digital footprints fromWT and c-Jun OE/mice taken at 0, 7, 18, 21, 28, and 70 d after sciatic nerve crush used in sciatic functional index (SFI) analysis.
E, SFI results fromWT (n 11) and c-Jun OE/ (n 8)mice at different times after sciatic nerve crush. There is no significant difference betweenWT and c-Jun OE/mice. Two-way ANOVAwith
Bonferroni’s comparison: p 0.5545.
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nerves and of the CMT1A rat (Palumbo et al., 2002; Lupski and
Chance, 2005; Fledrich et al., 2012). Abnormalities of Remak
fibers, including the formation of membranous structures that
do not contact axons, which are seen in c-Jun OE/OE mice, are
also described in the My41, C22, and C3 mouse models of
CMT1A (Robertson et al., 2002; Verhamme et al., 2011). Last,
onion bulbs, which are prominent in human CMT1A nerves and
seen in rodent CMT1A models (Lupski and Chance, 2005; Fle-
drich et al., 2012), are also present in nerves of aged c-JunOE/OE
mice.
The histological changes outlined here for c-Jun OE/OE and
CMT1A nerves are generally not specific to these conditions, but
are also observed to a varying degree in a number of other non-
tumor-associated human nerve pathologies, mutant mouse nerves,
or in injured nerves. (Low, 1977; Haney et al., 1999; Chen et al.,
2003; Ling et al., 2005; Kagitani-Shimono et al., 2008; Ishii et al.,
2016). The relative paucity of disease-specific structural changes
in pathological nerves and the sloppy relationship between mo-
lecular and histological phenotype makes it hard to interpret a
particular histology in terms of a causal sequence.
Although the availability of binding partners or other ancillary
proteins are important regulators of c-Jun function, the levels of
c-Jun protein are likely to be a key factor in determining whether
c-Jun has beneficial or adverse effects on nerve biology. Previous
work shows that, already at low or moderate levels compatible
with myelination, c-Jun appears to promote neuron-supportive
signaling fromSchwann cells to neurons, including the activation
of trophic factors such as GDNF, whereas higher levels are
required to suppress myelin genes. Therefore, in the C3mouse
model of CMT1A, c-Jun is elevated, but this is not high enough
to disrupt myelin, although it enhances axonal survival and sensory
motor performance (Hantke et al., 2014). Similarly, in CMT1X
mice, c-Jun is elevated and increases GDNF expression, but does
not disrupt myelination (Klein et al., 2014).
In sum, the present results show that, although moderate
c-Jun increase is well tolerated during Schwann cell development
and remyelination after injury, strong elevation of c-Jun in
uninjured nerves suffices to induce significant hypomyelina-
tion pathology, implicating c-Jun in demyelinating neuropathies.
Conversely, we did not find a link between c-Jun elevation and
tumorigenesis, which is consistent with the fact that tumors do
not form after nerve injury, although c-Jun is strikingly elevated
as Schwann cells lose myelin differentiation and proliferate. We
also found that, after crush injury of OE/ nerves, myelination
and nerve function can be restored in the presence of c-Jun levels
that are high enough to promote axonal regeneration in mice in
which regeneration has been compromised by long-term dener-
vation or advanced age.
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